DcR3 Polyclonal Antibody

TNFRSF6B belongs to the tumor necrosis factor receptor superfamily. TNF receptor superfamily member 6b is postulated to play a regulatory role in suppressing FasL- and LIGHT-mediated cell death. It acts as a decoy receptor that competes with death receptors for ligand binding. Over-expression of this gene has been noted in gastrointestinal tract tumors. Read-through transcription into this gene from the neighboring upstream gene, which encodes regulator of telomere elongation helicase 1 (RTEL1), generates a non-coding transcript.

Introducing the DcR3 Polyclonal Antibody, a cutting-edge scientific tool designed to facilitate advanced research in the field of immunology. This high-quality antibody is meticulously crafted using state-of-the-art techniques, ensuring exceptional specificity and sensitivity for accurate and reliable results.

The DcR3 Polyclonal Antibody is derived from a diverse pool of immunized animals, resulting in a robust and versatile product capable of recognizing a wide range of target antigens. Its polyclonal nature allows for enhanced binding affinity, enabling researchers to detect even low-abundance antigens with utmost precision.

With its superior performance, this antibody is an invaluable asset for various applications, including immunohistochemistry, western blotting, and flow cytometry. Its exceptional sensitivity and specificity guarantee optimal signal-to-noise ratios, facilitating the identification and characterization of target proteins with unparalleled accuracy.

Furthermore, the DcR3 Polyclonal Antibody exhibits exceptional stability and reproducibility, ensuring consistent and reproducible results across experiments. Its long shelf life and reliable performance make it an ideal choice for long-term studies and large-scale projects.

In addition to its exceptional scientific capabilities, this antibody is manufactured in compliance with stringent quality control standards, guaranteeing batch-to-batch consistency and reliability. Each batch is thoroughly tested to ensure optimal performance, providing researchers with the utmost confidence in their experimental outcomes.

In summary, the DcR3 Polyclonal Antibody is a state-of-the-art scientific tool that offers exceptional sensitivity, specificity, and versatility for advanced immunological research. With its robust performance, reliability, and compliance with rigorous quality control standards, this antibody is an indispensable asset for researchers seeking to unravel the complexities of the immune system and advance scientific knowledge in the field.